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ABSTRACT  
This cross sectional study assessed intellect, cognition, academic function, behaviour, 
and emotional health of long-term survivors after childhood liver transplantation. 
Eligible children were >5 years post transplant, still attending school, and resident in 
Queensland. Hearing and neurocognitive testing were performed on 13 transplanted 
children and 6 siblings including 2 twin pairs where one was transplanted and the 
other not. Median age at testing was 13.08 (range 6.52-16.99) years; time elapsed 
after transplant 10.89 (range 5.16-16.37) years; and age at transplant 1.15 (range 0.38-
10.00) years. Mean full scale intelligence quotient (IQ) was 97 (81-117) for 
transplanted children and 105 (87-130) for siblings. No difficulties were identified in 
intellect, cognition, academic function, and memory and learning in transplanted 
children or their siblings, although both groups had reduced mathematical ability 
compared to normal. Transplanted patients had difficulties in executive functioning, 
particularly in self regulation, planning and organisation, problem solving, and visual 
scanning. 31% (4/13) of transplanted patients, and no siblings, scored in the clinical 
range for ADHD.  Emotional difficulties were noted in transplanted patients but were 
not different from their siblings. Long-term liver transplant survivors exhibit 
difficulties in executive function and are more likely to have ADHD despite relatively 
intact intellect and cognition.   
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INTRODUCTION 
Liver transplantation is now the treatment of choice for many chronic childhood liver 
diseases with high rates of long-term survival (1). Outcomes after transplantation may 
ultimately be judged on the quality of life restored, incorporating both survival and 
quality of time survived (2). Cognitive functioning, academic ability, behaviour and 
psychosocial function in these survivors will all impact on their quality of life and 
ability to function within society.  
Children with end-stage liver disease are vulnerable to cognitive deficits and 
have been reported to have lower performance intelligence quotient (IQ) compared to 
age-matched children with cystic fibrosis; with primary diagnosis, age of onset, 
duration and severity of disease all impacting on their performance (3). Paediatric 
liver transplant survivors as a group have been reported to have lower IQ than their 
peers in several studies with follow up times up to 10 years post transplant (4-7). IQ 
alone, however, is not a good predictor of school performance and overall outcome, 
with poor correlation between intellectual functioning (IQ) and academic outcome in 
children after liver transplantation (4). IQ scores also fail to describe subtle cognitive 
deficits and more focused neuropsychological testing is necessary to provide 
information on specific and subtle cognitive deficits (7). Stewart and her collaborators 
from Dallas in their seminal work from the early 1990s identified that these children 
may have subtle cognitive impairments despite relatively normal, albeit in the lower 
range, intellectual functioning (4, 8, 9).  
There are methodological concerns with many of these outcome studies 
including small sample size, variation in the types of tests used, and a general lack of 
long-term data (7, 10, 11). Additionally, the timing of assessment and age at testing 
varies significantly, making comparisons between centres difficult, which may 
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contribute to conflicting and confusing results. These contrasting findings and lack of 
specific rather than gross overall outcomes call for further studies examining long-
term cognitive and academic functioning of patients who have undergone liver 
transplantation in childhood. 
The aims of our study therefore were to assess cognitive and academic 
function, general behaviour, and emotional health of long-term survivors after liver 
transplantation in childhood. In this study, siblings will be used as controls rather than 
those with other chronic illness as siblings are a better indicator of potential within 
individual family context and are also subject to the same environmental factors.  
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METHODS 
The Queensland Liver Transplant Service (QLTS) commenced in 1985 and was a 
major referral centre for paediatric liver transplantation for Australia, New Zealand 
and Asia until the mid 1990s when other centres developed their own programs. 
Patients surviving ≥5 years after initial transplant were considered long-term 
survivors. Long-term survivors who were being followed by QLTS, and were 
attending school (i.e. aged 6-18 years) were potentially eligible to participate in this 
study. The state of Queensland covers a geographic area of 1.72 million square 
kilometres, so regular review in Brisbane, the state capital, where QLTS is based is 
difficult for those living remotely and for inter-state patients. This study was restricted 
to those currently resident in Queensland and mainly Brisbane, due to difficulty in 
getting regional and out of state patients tested. Only patients reviewed in Brisbane 
during the study time frame (2006-2007) were recruited as neuropsychological 
assessment was only available in Brisbane. This study was approved by the Ethics 
Committee of the Royal Children’s Hospital, Brisbane. 
Hearing assessment was performed by an audiologist prior to psychometric 
testing to ensure that hearing loss did not impact on their psychometric test 
performance. Hearing tests performed included pure tone audiometry, tympanometry 
and transient evoked otoacoustic emissions testing.  
Standardised psychometric assessment was performed by the same 
neuropsychologist (OL). Tests included: 
• Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV) 
(12), which assesses intellectual functioning in children, aged 6-17 years 
of age. It yields an overall IQ index score as well as four index scores for 
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Verbal Comprehension (verbal cognitive functioning), Perceptual 
Reasoning (nonverbal cognitive functioning), Working Memory, and 
Speed of Information Processing, as composite scores based on ten 
individual subsets in these domains.  
• Wechsler Individual Achievement Test – Second Edition (WIAT-II) – 
Abbreviated (13) was used as a screen of academic functioning. The 
abbreviated form consists of three subtests, assessing reading, 
mathematical achievement, and spelling. 
• Wide Range Assessment of Memory and Learning – Second Edition 
(WRAML-2) (14) measures verbal and nonverbal learning and memory in 
children and adults aged 5-85 years. The Story Memory, Verbal Learning, 
Design Memory, and Picture Memory subtests were administered.  
• Rey-Osterrieth Complex Figure Test (RCFT) (15). The Rey Figure is a 
measure of visual-perceptual functioning (copy trial) and visual memory 
(recall and recognition trials).  
• Several subtests from the Delis-Kaplan Executive Functioning System 
(DKEFS) were administered as measures of executive functioning (16-
18):   
o Trail Making Test assesses attention control and cognitive 
flexibility  
o Verbal Fluency measures verbal generativity and cognitive 
flexibility 
o Colour-Word Interference Test assesses inhibition/impulse control 
o Tower Test assesses planning and goal setting. 
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• The Behaviour Rating Inventory of Executive Functioning (BRIEF) 
parent form measures parental perceptions of a child’s executive 
functioning in everyday life (19, 20).  
• The Conners Parent Rating Scale-Revised is a measure of a child’s 
behavioural functioning, particularly in relation to attention and 
hyperactivity (21). 
• The Child Behaviour Check List (CBCL) is a parent-completed measure 
of a child’s emotional and behavioural functioning (22). 
All results were normalised for age and presented as mean ± SD. Transplanted 
patients were compared to sibling controls and both compared to population norms. 
Screening for violations of statistical assumptions was conducted. All non-categorical 
data were found to be normally distributed. As such, parametric tests were able to be 
used to analyse the data. Student’s t test was also used to obtain p values although it is 
acknowledged that interpretation of these results is limited by low subject numbers 
Difference of means and 95% confidence intervals were used to compare mean test 
results between transplanted patients and controls. The Fisher exact test was used to 
compare categorical variables. 
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RESULTS 
The Queensland Liver Transplant Service (QLTS) performed 273 liver transplants in 
231 children aged <18 years between 1985 until the end of 2004. 76% (176/213) 
survived at least 5 years after initial transplant although a further 17 patients died after 
that time. Only 61 of these long-term survivors were Australian residents, of which 38 
were identified to live in Queensland. Among the Queensland patients, 29 were 
attending school when this study was conducted.  
There were 13 transplant survivors and 6 siblings who consented to participate 
in this study. This cohort included 2 sets of twins where one was transplanted and the 
other not. The twins included a transplanted male and his twin sister, and a 
transplanted female and her twin sister. There were 6 boys and 7 girls in the 
transplanted group while all 6 siblings were female. Median age at testing was 13.08 
(range 6.52-16.99) years for transplanted children and 10.99 (range 8.76-14.99) years 
for controls, which was not significantly different (p=0.42). The median time after 
transplant was 10.89 (range 5.16-16.37) years, and median age at transplant was 1.15 
(range 0.38-10.00) years in participants. 
There were 16 potentially eligible children (survived >5 years post transplant, 
attending school, and resident in Queensland) who did not participate in this study. 
The demographics of our subjects and non-participants are shown in Table 1. There 
were no differences in gender, age at transplant, PELD score, height Z scores at 
transplant, diagnosis of biliary atresia, transplant era, or time after transplant when 
compared with those participating in the study. Time after transplant was calculated to 
the date of testing for subjects. For non-participants, time after transplant was 
calculated to Jan 25, 2007, which was the median date of testing. More participants 
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were on cyclosporine while more non-participants were on tacrolimus at the time of 
this study.  
All children had their hearing tested prior to psychometric assessment. No 
child had sensorineural hearing loss and all had normal transient evoked otoacoustic 
emissions, indicating normal outer hair cell function despite exposure to ototoxins. 
Two transplanted children had mild conductive hearing loss, one with mild-moderate 
conductive loss and the other with Eustachian tube dysfunction. None had hearing 
impairment that was significant enough to preclude or affect psychometric testing. 
On the WISC-IV testing, no significant difference was found in full scale IQ 
between transplanted and control patients, with mean IQ 97 (range 81-117) vs. 105 
(range 87-130) respectively (Table 2). All children tested had IQ scores in the normal 
range except for 1 control sibling with significantly above average intellectual 
functioning with full scale IQ of 130. Specifically, no transplanted child had a full 
scale IQ less than 80. No differences were found in either transplanted patients or 
sibling controls compared to normative data in IQ, verbal comprehension, perceptual 
organisation, working memory, and processing speed. When academic function was 
tested with the WIAT-II Abbreviated, no differences in word reading, numerical 
operations and spelling between transplanted and control children were found (Table 
2). Both groups, however, had significantly reduced numerical operation ability 
compared to normative data (p=0.001 for transplants, and p=0.01 for controls). 
Cognitive function was assessed via subtests of the WISC-IV (Table 3). There 
was little difference between transplanted patients and controls in all subtests.  No 
visual–spatial difficulties were identified in transplanted patients. When compared to 
the normal population, however, siblings performed better than average in coding, a 
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measure of speed of information processing; and in comprehension, which measures 
verbal reasoning and conceptualization, and social judgement and maturation.  
Memory and learning was assessed with WRAML-2 and RCF tests (Table 4). 
Transplanted patients had reduced scores in all subtests of Story Memory compared to 
controls, although further examination of data revealed that this was due to control 
patients performing significantly better than normal (p=0.001). No difference was 
found between transplanted patients and sibling controls on other WRAML-2 subsets 
of verbal learning, design or picture memory. On the RCFT, although no difference 
was noted between groups, both performed below population normal for Intermediate 
and Delayed Recall (p=0.03, and p=0.01 respectively for transplanted patients). 
Executive function was tested directly with the DKEFS, and indirectly with 
parents completing the BRIEF questionnaire (Table 5).  Transplanted patients had 
more rule violations in the tower test on the DKEFS, which indicates difficulties with 
self-regulation, and maintenance of cognitive and instructional set, compared to 
siblings and normative data. Interestingly, these difficulties were also noted on the 
parent-reported BRIEF where transplanted patients had more reported difficulties in 
initiation, planning and organisation, compared to their siblings. Sibling controls 
performed above age-appropriate expectations in switching and inhibition on the 
Colour-Word Interference subtest of the DKEFS. Visual scanning on the Trail 
Making subtest was also reduced in transplanted patients compared to siblings. 
On the Conners Rating Scale-Revised, transplanted patients scored higher than 
their siblings in Attention Deficit Hyperactivity Disorder (ADHD), inattention, and 
DSM-IV: Inattention indices (Table 6). While the mean ADHD Index score in 
transplanted patients was less than 60, the conventional cut off associated with 
clinical significance, 4/13 (31%) transplanted patients scored above this, whereas no 
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sibling scored in the clinically significant range. There were no significant differences 
in the other domains of emotional and behavioural function between transplanted 
patients, their siblings, and normative data. Aside from attention problems, there were 
no significant differences between transplanted children and their sibling controls on 
behavioural assessment on the CBCL (Table 6). However, when compared with 
normative data, transplanted children were significantly more anxious (p=0.02), 
withdrawn with depressive behaviour (p=0.01), had increased somatic complaints 
(p=0.004), social (p=0.03), thought (p=0.004) and attention (p=0.002) problems, 
increased rule breaking (p=0.03), and more aggressive behaviour (p=0.01). Siblings 
however also scored higher than normative data in all these domains resulting in little 
difference between the groups.  
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DISCUSSION 
These results show transplant recipients performing better than previously reported, 
with mean IQ scores in the normal range and similar to their siblings. While some 
difficulties with mathematics were noted in the transplanted children, this was similar 
to their siblings. Potential reasons for discrepancies in IQ scores between studies 
include variations in tests used, age at assessment, era of transplantation, time from 
transplant, ongoing chronic illness, malnutrition, and post transplant event free 
survival. A potential explanation for our cohort performing better than previously 
reported is the increased time since transplant. Unlike previous studies, which were 
often a mixture of short to long-term survivors, this sample was restricted to only 
long-term survivors with median follow up time of 10.89 years after transplant, which 
is longer than previously reported. We also used the same tests in all patients, as they 
were all school aged, to avoid differences between assessment methods.  
We are not the only group to report normal mean IQ in transplanted patients. 
Two recent North American studies have reported their cohorts to have full scale IQ 
in the normal range (23, 24). Robertson et al from Edmonton, Canada, found mean 
full scale IQ of 93.9 in a study of 33 children, 89% of their transplant cohort, at 
kindergarten entry (23). The SPLIT consortium, reported mean full scale IQ 94.7 in a 
study of 144 children aged 5-7 years, although only 32% of potentially eligible 
patients participated in this study (24). Of concern, 30% of their cohort had evidence 
of intellectual impairment, but interestingly, an earlier report by this group found the 
most important predictor of educational support after transplant was the requirement 
for educational support pre-transplant, Odds Ratio 22.5 (25). They concluded that 
non-transplant factors were important in determining post transplant outcomes (25). 
While chronic illness in the pre-transplant phase may result in underachievement, 
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inherent ability of the child or the family environment is also likely to be a significant 
contributor. The use of siblings as controls in our study therefore enabled us to 
exclude family factors such genetic potential and family environment on these 
children’s performances.  
It is likely however that with advances in the management of chronic liver 
disease and improved outcomes of liver transplant patients over time, using gross 
measures such as IQ assessment will be insufficient and more specific testing is 
necessary to adequately assess neurocognitive function. In recognition of this, we 
assessed our cohort for more subtle cognitive deficits including executive functioning. 
In contrast to previous studies, which were reliant on parent or teacher reports, we 
assessed executive functioning directly. Transplanted patients exhibited difficulties 
with goal setting, problem solving, self-regulation, and maintenance of cognitive set, 
with divided attention and impulsivity. While these difficulties generally did not 
translate to reduced academic function on assessment, these changes are likely to 
affect their function in adulthood. These findings suggest that transplanted patients 
may have difficulty multi-tasking and following instructions, which may then affect 
compliance with medical care and cause problems in the work environment. Visual 
scanning was also reduced in transplanted patients. Difficulties with visual scanning 
are associated with increased risk of accidents when controlling motor vehicles (26).  
Transplanted patients scored higher on the ADHD index on Conners testing 
than their siblings. Of relevance, 31% (4/13) of transplanted patients had clinically 
significant scores whereas none of the siblings did. While a gender effect was 
considered since all sibling controls were female, three of the four patients who 
scored in the clinical range were female. Interestingly, although transplanted patients 
were more anxious, had more somatic complaints and more thought problems than 
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normal, they were not different to their siblings. This suggests that chronic illness in 
one member affects the whole family and it would be interesting to assess the 
psychosocial and mental health of parents as parental stress is recognised to affect the 
behaviour and psychosocial health of all children, including the physically healthy, in 
the family, as is seen in children with acquired brain injury (27).  
This study is limited by low patient numbers, despite recruiting 45% of 
potentially eligible patients in our centre, which may impact on interpretation of data. 
No differences, however, were noted between study subjects and non-participants, 
except for current calcineurin inhibitor therapy, but this is unlikely to be clinically 
significant. As such, the sample is thought to be relatively representative of long-term 
survivors of liver transplantation. The use of sibling controls, particularly the two sets 
of twins, adds weight to these findings. While the other limitation of our study was 
that all the control siblings were female and were not aged matched, the difficulties 
identified remained even when compared to the normal population, excluding a 
gender effect.  
  The findings of this study are important as it is the first study to directly assess 
the executive function of transplanted patients, rather than rely on parent or teacher 
reporting. It is also the only study to use siblings as controls to preclude the effect of 
genetic and family environment affecting outcomes. The twin pairs add weight to 
these findings despite our low numbers and lack of age matching for the rest of the 
cohort. We also report the longest follow up time with median 10.89 years post liver 
transplant for comprehensive neuropsychological testing. 
These results are encouraging and better than previously reported with normal 
full scale IQ, cognition, and academic function in long-term survivors after liver 
transplantation. The emotional difficulties identified were also present in siblings 
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suggesting environmental rather than biological illness effect. While these results 
suggest it may be possible for long-term survivors of childhood liver transplant to 
achieve their underlying potential in gross testing such as IQ and academic function, 
ongoing difficulties in executive function and increased likelihood of ADHD will 
likely be relevant. Further studies examining these more subtle psychometric changes, 
particularly in executive function and behaviour are necessary. Collaborative multi-
centre studies are likely to be necessary to generate appropriate patient numbers. 
Routine clinical assessment of cognitive functioning, including executive functioning, 
and behaviour post transplant is recommended. 
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Table 1: Demographics of eligible transplanted patients 
 Subjects (n=13) Others (n=16) p value 
Boys 46% (n=6) 44% (n=7) 1.00 
Median age at OLT (yrs) 1.15 (0.38-10.00) 0.86 (0.58-7.62) 0.83 
Mean PELD score 13.4 15.7 0.41 
Mean Height Z at OLT -1.20 ± 1.36 -1.29 ± 1.48 0.86 
Median time post OLT (yrs) 10.89 (5.16-16.37) 11.08 (6.78-16.88)^ 0.86 
DIAGNOSIS    
Biliary Atresia 8 14 0.19 
Alagille 3 1  
A1AT 1 0  
PFIC 1 0  
Crigler-Najjer Syndrome 0 1  
TRANSPLANT ERA    
>2000 7.7% (n=1) 0  
1991-2000 84.6% (n=11) 88% (n=14) 1.00 
≤1990 7.7% (n=1) 12% (n=2)  
IMMUNOSUPPRESSION    
Tacrolimus 38% (n=5) 75% (n=12) 0.07 
Cyclosporine 54% (n=7) 25% (n=4) 0.14 
Other  8% (n=1) 0  
^ Time from transplant in non-participants was calculated to 25 Jan 2007; the median 
date when psychometric testing was undertaken in subjects.  
OLT: Orthotopic Liver Transplant; PELD: Pediatric End-stage Liver Disease; A1AT: 
Alpha-1-antitrypsin deficiency; PFIC: Progressive Familial Intrahepatic Cholestasis 
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Table 2: Intellectual and academic function (WISC-IV and WIAT-II tests) 
Specific Tests Transplant  
(n=13) 
Controls 
(n=6) 
Diff. of 
means 
95% CI p value 
WISC-IV      
Full scale IQ 97.38±11.59 105.17±16.12 -7.79 -21.42 to 5.84 0.30 
Verbal 
comprehension 97.31±10.79 108.83±16.38 
 
-11.52 
 
-24.74 to 1.70 0.13 
Perceptual 
organisation 100.77±16.19 101.67± 21.29 
 
-0.90 
 
-19.48 to 17.68 0.93 
Working memory 97.08±9.38 99.67± 6.56 -2.59 -11.59 to 6.41 0.50 
Processing speed 95.92±11.32 104.00±10.51 -8.08 -19.63 to 3.47 0.15 
WIAT-II      
Word reading 96.00±14.79 99.50±15.24 -3.5 -19.04 to 12.04 0.64 
Numerical 
operations 86.15±12.92 92.33± 9.14 
 
-6.18 
 
-18.61 to 6.25 0.19 
Spelling 98.15±13.26 100±10.75 -1.85 -14.94 to 11.24 0.75 
Diff. of means: Difference of means; CI: Confidence Interval; WISC-IV: Wechsler 
Intelligence Scale for Children -Fourth Edition; WIAT-II: Wechsler Individual 
Achievement Test -Second Edition 
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Table 3: Cognitive Function (WISC-IV subtests) 
Specific Tests Transplant  
(n=13) 
Controls 
(n=6) 
Diff. of 
means 
95% CI p value 
Block design 9.38±2.47 10.33±4.46  -0.95 -4.27 to 2.37 0.93 
Similarities 9.23±2.59 12.17±3.37 -2.94 -5.9 to 0.02 0.34 
Digit Span 9.69±2.36 9.83±1.72 -0.14 -2.42 to 2.14 1.00 
Picture Concepts 9.92±3.35 10.00±2.61 -0.08 -3.36 to 3.2 0.93 
Coding 9.46±1.98 11.33±1.63 -1.87 -3.83 to 0.09 0.19 
Vocabulary 9.23±2.35 10.17±3.37 -0.94 -3.74 to 1.86 0.81 
Letter-Number 9.46±1.76 10.33±1.21 -0.87 -2.56 to 0.82 0.16 
Matrix Reasoning 11.00±3.34 10.50±4.37 0.50 -3.32 to 4.32 0.47 
Comprehension 10.31±1.75 12.33±2.34 -2.02 -4.04 to 0.00 0.03 
Symbol Search 9.15±2.44 10.83±1.83 -1.68 -4.05 to 0.69 0.46 
Diff. of means: Difference of means; CI: Confidence Interval; WISC-IV: Wechsler 
Intelligence Scale for Children -Fourth Edition 
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Table 4: Memory and Learning (WRAML2 and RCFT tests) 
Specific Tests Transplant  
(n=13) 
Controls 
(n=6) 
Diff. of 
means 
95% CI p value 
WRAML-2      
Verbal Learning: 
Immediate 
 
10.92±3.55 
 
9.67±3.88 
 
1.25 
 
-2.55 to 5.05 
 
0.37 
Delayed 10.38±3.36 10.00±3.29 0.38 -3.10 to 3.86 0.08 
Recognition 10.73±2.65 11.50±2.96 -0.77 -3.75 to 2.21 0.71 
Story Memory: 
Immediate 
 
10.85±2.82 
 
14.17±2.14 
 
-3.32 
 
-6.07 to -0.57 
 
0.05 
Delayed 10.85±2.54 14.00±1.41 -3.15 -5.51 to -0.79 0.02 
Recognition 10.92±2.43 13.50±1.22 -2.58 -4.82 to -0.35 0.17 
Design Memory: 
Immediate 
 
9.23 ±3.14 
 
9.83±1.72 
 
-0.60 
 
-3.51 to 2.31 
 
0.82 
Recognition 9.31±2.53 9.83±3.06 -0.52 -3.33 to 2.29 0.82 
Picture Memory: 
Immediate 
 
9.62±2.69 
 
11.00±1.26 
 
-1.38 
 
-3.84 to 1.08 
0.53 
Recognition 10.15±2.91 9.80±3.42 0.35 -3.05 to 3.75 0.69 
Finger Windows 8.92±2.47 9.67±3.27 -0.75 -3.59 to 2.09 0.94 
Number-Letter 10.081±2.93 10.17±1.72 -0.09 -2.83 to 2.65 0.57 
RCFT      
RCFT: Immediate 36.10±28.71 30.00±26.04 6.10 -23.48 to 35.68 0.50 
RCFT: Delayed 28.82±25.60 32.50±30.38 -3.68 -34.26 to 26.91 0.78 
RCFT: Recognition 52.10±28.96 54.20±40.19 -2.10 -39.77 to 35.57 0.43 
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Diff. of means: Difference of means; CI: Confidence Interval; WRAML-2: Wide 
Range Assessment of Memory and Learning –second edition; RCFT: Rey-Osterrieth 
Complex Figure Test 
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Table 5: Executive Functioning (DKEFS and BRIEF) 
Specific Tests Transplant  
(n=13) 
Controls 
(n=6) 
Diff. of 
means 
95% CI p value 
DKEFS      
Visual Scanning 8.67±2.15 11.50±2.51 -2.83 -5.24 to -0.42 0.03 
Number Sequencing 8.08±4.12 10.67±1.97 -2.59 -6.39 to 1.21 0.43 
Letter Sequencing 8.42±2.27 11.00± 3.16 -2.58 -5.32 to 0.16 0.16 
Switching 8.00±4.09 12.00±2.00 -4.00 -7.78 to -0.22 0.09 
Motor 8.30±3.68 9.50±5.80 -1.2 -6.46 to 4.06 0.84 
Letter Fluency 9.08±3.12 11.83±3.19 -2.75 -6.08 to 0.58 0.30 
Category Fluency 12.45±3.47 12.50±2.74 -0.05  -3.56 to 3.46 0.87 
Category Switching 10.55± 3.30 12.00±3.94 -1.45 -5.49 to 2.59 0.40 
Switching Accuracy 11.55±3.14 11.80±2.77 -0.25 -3.77 to 3.26 0.61 
Colour Naming 10.75±2.30 11.67±2.07 -0.92 -3.28 to 1.44 0.07 
Word Naming 9.67±2.35 10.67±2.88 -1.00 -3.68 to 1.68 0.12 
Inhibition 9.75±2.05 13.33±1.97 -3.58 -5.73 to -1.44 0.04 
Inhibition/Switch 9.33±3.14 10.67±3.56 -1.34 -4.81 to 2.13 0.75 
Tower Test Total 11.25± 2.70 10.33±2.88 0.92 -2.01 to 3.84 0.78 
Tower Rule Violation 61.17±48.15 30.17±37.82 31.00 -16.85 to 78.88 0.28 
BRIEF      
Inhibit 51.46±11.76 46.17±8.54 5.29 -6.07 to 16.65 0.88 
Shift 49.46±11.09 51.50±12.97 -2.04 -14.20 to 10.12 0.95 
Emotional Control 48.31±10.62 46.00±7.87 2.31 -7.99 to 12.61 0.66 
Initiate 56.92±16.23 45.67±8.73 11.25 -3.78 to 26.28 0.30 
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Working Memory 57.15±14.29 47.50±8.02 9.65 -3.65 to 22.95 0.39 
Planning/Organisation 57.62±11.82 44.33±10.27 13.29 1.43 to 25.15 0.13 
Organising Materials 50.46±11.68 43.67±9.83 6.79 -4.84 to 18.42 0.17 
Monitor 51.69±11.57 43.67±12.08 8.02 -4.19 to 20.23 0.23 
Behavioural Regulation 
Index 
46.00±15.88 47.33±0.03 -1.33 -16.33 to 13.67 0.74 
Metacognition Index 55.85±12.66 47.17±12.43 8.68 -4.43 to 21.79 0.35 
Global Executive 
Composite 
53.62±11.72 44.83±10.98 8.79 -3.19 to 20.77 0.30 
Diff. of means: Difference of means; CI: Confidence Interval; DKEFS: Delis-Kaplan 
Executive Function Test; BRIEF: Behaviour Rating Inventory of Executive Function 
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Table 6: Behaviour and Emotional Function (Conners Parent Rating Scale & CBCL) 
Specific Tests Transplant  
(n=13) 
Controls 
(n=6) 
Diff. of 
means 
95% CI p value 
Conners      
Oppositional  49.38±7.48 46.33±5.35 3.05 -4.16 to 10.25 0.45 
Cognitive Problems / 
Inattention 
56.31±14.17 47.83±7.76 8.48 -4.67 to 21.63 0.41 
Hyperactivity 51.08±11.05 50.67±8.43 0.41 -10.36 to 11.19 0.48 
Anxious / Shy 53.00±10.26 47.83±5.38 5.17 -4.31 to 14.64 0.26 
Perfectionism 49.77±7.33 48.67±5.82 1.10 -6.10 to 8.31 0.31 
Social Problems 53.62±13.26 53.00±12.39 0.62 -12.93 to 14.17 0.89 
Psychosomatic 51.08± 13.71 49.33±11.76 1.75 -11.96 to 15.46 0.72 
ADHD Index 55.31±14.01 45.67±5.99 9.64 -3.07 to 22.36 0.35 
Restless & Impulsive 51.69±9.18 47.83±6.05 3.86 -4.87 to 12.58 0.90 
Emotional Lability 49.46±8.19 45.33±4.72 4.13 -3.52 to 11.77 0.09 
Index: Total 50.62±7.26 46.50±4.04 4.12 -2.63 to 10.87 0.34 
DSM-IV: Inattentive 54.77±12.79 47.17±5.74 7.60 -4.05 to 19.25 0.37 
DSM-IV: 
Hyperactive-
Impulsive 
53.00±12.09 49.50±7.34 3.50 -7.86 to 14.86 0.93 
DSM-IV: Total 54.69±13.33 47.33±4.41 7.36 -4.57 to 19.28 0.48 
CBCL      
Anxious/ Depressed 55.00±6.39 52.67±6.53 2.33 -4.37 to 9.03 0.42 
Withdrawn / 56.54±8.25 54.5±6.98 2.04 -6.18 to 10.26 0.53 
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Depressed 
Somatic Problems 58.54±8.85 55.00±10.35 3.54 -6.16 to 13.24 0.13 
Social Problems 55.00±7.16 55.67±12.91 -0.67 -10.28 to 8.94 0.89 
Thought Problems 57.92±7.88 56.50±9.29 1.42 -7.24 to 10.08 0.56 
Attention Problems 59.15±8.50 53.50±6.25 5.65 -2.58 to 13.88 0.49 
Rule-breaking 
Behaviour 
53.92±5.65 53.33±8.16 0.59 -6.17 to 7.35 0.97 
Aggressive 
Behaviour 
55.31±5.23 52.83±6.01 2.48 -3.22 to 8.17 0.59 
Internalising 53.46±12.94 45.33±15.08 8.13 -6.04 to 22.30 0.09 
Externalising 51.38±8.98 45.50±12.55 5.88 -4.70 to 16.46 0.38 
Total 53.62±9.64 43.83±16.40 9.79 -2.74 to 22.32 0.20 
Diff. of means: Difference of means; CI: Confidence Interval; CBCL: Child 
Behaviour Check List; ADHD Index: Attention Deficit Hyperactivity Disorder Index; 
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders- 4th edition. 
 
